Surface Ophthalmics

News

Surface Pharmaceuticals, Inc. Announces $20 Million Series A Financing From Flying L Partners

Reuters

May 15 (Reuters) – Imprimis Pharmaceuticals Inc:

* SURFACE PHARMACEUTICALS, INC. ANNOUNCES $20 MILLION SERIES A FINANCING FROM FLYING L PARTNERS

* IMPRIMIS PHARMACEUTICALS – SURFACE PHARMA INTENDS TO USE PROCEEDS OF FINANCING TO ADVANCE CLINICAL DEVELOPMENT PROGRAMS FOCUSED ON OCULAR SURFACE DISEASE Source text for Eikon: Further company coverage: